From: Adaptive propensity score procedure improves matching in prospective observational trials
Interim | Final | Interim | Final | |
---|---|---|---|---|
n control | Naiv | 99%-CI | ||
50 | 0.89 | 0.79 | 0.49 | 0.92 |
75 | 0.93 | 0.81 | 0.58 | 0.92 |
100 | 0.95 | 0.82 | 0.64 | 0.92 |
125 | 0.96 | 0.83 | 0.67 | 0.92 |
150 | 0.97 | 0.84 | 0.70 | 0.92 |
175 | 0.98 | 0.84 | 0.72 | 0.92 |
200 | 0.98 | 0.84 | 0.73 | 0.92 |
225 | 0.98 | 0.85 | 0.74 | 0.92 |
250 | 0.99 | 0.85 | 0.76 | 0.92 |
275 | 0.99 | 0.85 | 0.76 | 0.92 |
300 | 0.99 | 0.86 | 0.77 | 0.92 |
95%-CI | 90%-CI | |||
50 | 0.54 | 0.91 | 0.56 | 0.90 |
75 | 0.62 | 0.91 | 0.64 | 0.90 |
100 | 0.67 | 0.91 | 0.68 | 0.91 |
125 | 0.70 | 0.91 | 0.71 | 0.91 |
150 | 0.72 | 0.91 | 0.73 | 0.91 |
175 | 0.74 | 0.91 | 0.75 | 0.91 |
200 | 0.75 | 0.91 | 0.76 | 0.91 |
225 | 0.76 | 0.91 | 0.77 | 0.91 |
250 | 0.77 | 0.91 | 0.78 | 0.91 |
275 | 0.78 | 0.91 | 0.79 | 0.91 |
300 | 0.79 | 0.91 | 0.80 | 0.91 |